Who owns COLLPLANT BIOTECHNOLOGIES LT?
- Ticker: CLGN
- CUSIP Number: m2r51x116
Tip: Access positions for across all investors
Analyze quarterly positions in Collplant Biotechnologies Lt with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Collplant Biotechnologies Lt stock
Who bought or sold COLLPLANT BIOTECHNOLOGIES LT this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Gail Mannix | 531k | $2.8M | 13% | Mar 2024 |
|
St. Denis J. Villere & Co | 367k | $2.0M | 2% | Mar 2024 |
|
Brown Advisory Holdings Incorporated | 120k | $640k | 60% | Mar 2024 |
|
Benjamin F. Edwards & Company | 51k | $272k | 1% | Mar 2024 |
|
Citadel Advisors | 14k | $75k | 36% | Mar 2024 |
|
Bank of America Corporation | 7.3k | $39k | 0% | Mar 2024 |
|
UBS Group | 4.8k | $26k | 100% | Mar 2024 |
|
Pnc Financial Services | 3.6k | $19k | 0% | Mar 2024 |
|
National Bank Of Canada /fi/ | 250.00 | $1.5k | 0% | Dec 2023 |
|
Qube Research & Technologies | 6.00 | $31.999800 | 0% | Mar 2024 |
|
Morgan Stanley | 1.00 | $9.000000 | -99% | Mar 2024 |
|
Who sold out of Collplant Biotechnologies Lt?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Zurcher Kantonalbank | Dec 2023 | 23k | $148k |
FNY Investment Advisers | Dec 2023 | 1.5k | $9.0k |
Goss Wealth Management | Sep 2023 | 500.00 | $2.8k |
Jpmorgan Chase & Co | Dec 2023 | 371.00 | $2.4k |
Focused Wealth Management | Dec 2023 | 242.00 | $1.5k |